Src homology 2 domain-containing inositol 5′ phosphatase is negatively associated with histamine release to human recombinant histamine-releasing factor in human basophils

Journal of Allergy and Clinical Immunology

Volumn 108, Issue 5, 2001, Pages 822-831

  Vonakis, Becky M ^a   Gibbons Jr, Scott ^a   Sora, Rebecca ^a   Langdon, Jacqueline M ^a   MacDonald, Susan M ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Basophil; Cellular activation; Cytokines; Signal transduction

Indexed keywords

INOSITOL 5' PHOSPHATASE; PHOSPHATASE; UNCLASSIFIED DRUG;

ALLERGY; ARTICLE; BASOPHIL; HISTAMINE RELEASE; HUMAN; HUMAN CELL; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEQUENCE HOMOLOGY; SIGNAL TRANSDUCTION;

EID: 0035179517     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1067/mai.2001.119159     Document Type: Article

References (54)

1. Molecular identification of an IgE-dependent histamine releasing factor
2. An immunoglobulin E-dependent recombinant histamine releasing factor induces IL-4 secretion from human basophils
3. Studies of IgE-dependent histamine releasing factors: Heterogeneity of IgE
4. Recombinant histamine-releasing factor enhances IgE-dependent IL-4 and IL-13 secretion by human basophils
5. Pharmacologic regulation of histamine release by the human recombinant histamine-releasing factor
6. The human recombinant histamine releasing factor: Functional evidence that it does not bind to the IgE molecule
7. Human recombinant histamine-releasing factor activates human eosinophils and the eosinophilic cell line, AML 14-3D10
8. Recombinant IL-3 induces histamine release from human basophils
9. 2O sensitivity
10. Basophil "releasibility" in patients with asthma
11. A comparative study of releasing and nonreleasing human basophils: Nonreleasing basophils lack an early component of the signal transduction pathway that follows IgE cross-linking
12. Syk deficiency in nonreleaser basophils
13. The tyrosine kinases p53/56lyn and p72syk are differentially expressed at the protein level but not at the messenger RNA level in nonreleasing human basophils
14. Signal transduction for secretion in basophils
15. The 145-kDa protein induced to associate with Shc by multiple cytokines is an inositol tetraphosphate and phosphatidyl 3,4,5-trisphosphate 5-phosphatase
16. p150ship a signal transduction molecule with inositol polyphosphate-5-phosphatase activity
17. Multiple forms of an inositol polyphosphate 5-phosphatase form signaling complexes with Shc and Grb2
18. Lipid phosphatases in the immune system
19. Role of the inositol phosphatase SHIP in negative regulation of the immune system by the receptor Fc-gamma-RIIB
20. The negative signaling molecule SH2-domain containing inositol-polyphosphate 5-phosphatase (SHIP) binds to the tyrosine-phosphorylated beta subunit of the high affinity IgE receptor
21. Negative regulation of FcεRI signaling by FcgRII costimulation in human blood basophils
22. The src homology 2-containing inositol phosphatase (SHIP) is the gatekeeper of mast cell degranulation
23. Monomeric IgE stimulates signaling pathways in mast cells that lead to cytokine production and cell survival
24. Inhibition of basophil histamine release by antiinflammatory steroids. II. Studies on the mechanism of action
25. Refinements in the automated fluorometric histamine analysis system
26. Downregulation of FcεRI expression on human basophils during in vivo treatment of atopic patients with anti-IgE antibody
27. Phosphatidylinositol-3 kinase regulates p21ras activation during IgE-mediated stimulation of human basophils
28. Dual phase priming by IL-3 for leukotriene C4 generation in human basophils: Difference in characteristics between acute and late priming effects
29. Real time quantitative PCR
30. A specific inhibitor of phosphatidylinositol 3-kinase. 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one (LY294002)
31. Inhibitors of PI 3-kinase and MEK kinase differentially affect mediator secretion from immunologically activated human basophils
32. The clinical relevance of basophil releasibility
33. The concept of basophil releasability
34. Human basophil releasability. I. Age-related changes in basophil releasability
35. Human basophil releasability. III. Genetic control of human basophil releasability
36. Exploiting the difference between intrinsic and extrinsic kinases: Implications for regulation of signaling by immunoreceptors
37. One lyn molecule is sufficient to initiate phosphorylation of aggregated high-affinity IgE receptors
38. The mapping of the Lyn kinase binding site of the common β subunit of IL-3/granulocyte-macrophage colony-stimulating factor/IL-5 receptor
39. Transfection of Syk protein tyrosine kinase reconstitutes high affinity IgE-receptor-mediated degranulation in a Syk-negative variant of rat basophilic leukemia RBL-2H3 cells
40. Targeted disruption of SHIP leads to Steel factor-induced degranulation of mast cells
41. Targeted disruption of SHIP leads to hematopoietic perturbations, lung pathology, and a shortened life span
42. Tec family of protein-tyrosine kinases: An overview of their structure and function
43. Phosphatidyl-3,4,5-trisphosphate (Ptdlns-3,4,5-P3)/Tec kinase-dependent calcium signaling pathway: A target for SHIP-mediated inhibitory signals
44. Signalling through the high-affinity IgE receptor FcεRI
45. Capacitative calcium entry channels
46. Inhibitory signaling by the B cell FcγR1IB
47. Quantitative relationships between aggregation of IgE receptors, generation of intracellular signals and histamine secretion in rat basophilic leukemia (2H3) cells
48. The SH2-containing inositol polyphosphate 5-phosphatase, SHIP, is expressed during hematopoiesis and spermatogenesis
49. Cloning of the genomic locus of mouse SH2 containing inositol 5-phosphatase (SHIP) and a novel 110-kDa splice isoform, SHIPδ
50. BCR/ABL directly inhibits expression of SHIP, an SH2-containing polyinositol-5-phosphatase involved in the regulation of hematopoiesis
51. Multiple defects in FcεRI signaling in syk-deficient nonreleaser basophils and IL-3-induced recovery of syk expression and secretion
52. Clinical severity and thermodynamic effects of iron-responsive element mutations in hereditary hyperferritinemia-cataract syndrome
53. Hereditary hyperferritinemia-cataract syndrome: Relationship between phenotypes and specific mutations in the iron-response element of ferritin light-chain mRNA
54. Iron-regulatory proteins, iron-response elements and ferritin mRNA translation